On November 27, 2020 Australia’s Therapeutics Goods Administration (TGA) state on their website that they “will rigorously assess any COVID-19 vaccine for safety, quality and effectiveness before it can be supplied in Australia.”
On March 29, 2018 the Therapeutics Goods Act 1989 was amended to include a Provisional Registration clause to allow products to enter the system on limited data, not allowed for normal registration. The clause was sold on the intent of providing life-saving medication to cancer patinets, and to have our regulatory system was in line with the rest of the world – with a fast-track, emergency-like provision!